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Available online 24 June 2014AbstractAcute respiratory failure (ARF) is the main cause of cardiac arrest in children. Many studies suggest noninvasive ventilation (NIV) without
endotracheal tube intubation (ETI) in the treatment of pediatric ARF. However, there are many important considerations, such as identifying the
patient, proper timing for the NIV procedure, and the appropriate setting. We used NIV in a 6-year-old ARF patient and a 14-year-old ARF
patient. NIV can produce positive results in children with ARF as well as adults. In our two cases, we showed the acute setting and the use of
NIV at the right time.
Copyright © 2014, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Invasive mechanical ventilation (IMV) through an endo-
tracheal tube or tracheostomy has been used as a life-saving
treatment for acute respiratory failure (ARF) in past decades.
However, risks and complications have been associated with
endotracheal tube intubation (ETI).1 The use of noninvasive
ventilation (NIV) has become increasingly popular as a sup-
porting treatment for ARF in children.2e13 Compared to IMV,
NIV is much safer and has fewer complications, such as upper
airway trauma, laryngeal swelling, post-extubation vocal cord
dysfunction, and nosocomial infection.14 It has been proven to
reduce hospital admissions for ETI cases. We followed the
Bernd Sch€onhofer et al6 guidelines and used NIV in our units
prior to intubation to manage the above concerns. We believe* Corresponding author. 5F, Number 492-19, Section 1, Wan Shou Road,
Kwei Shan Hsiang, Taoyuan Hsien, Taiwan.
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2211-5587/Copyright © 2014, Taiwan Society of Emergency Medicine. Publishedthat early management of ARF could prevent such
complications.
Based on the reports of the Bureau of National Health In-
surance, the treatment of ARF in pediatric patients cost about
9 million United States dollars in 2009. When treating ARF,
physicians must be aware of the ideal type of ventilation
support for each individual patient to provide the greatest
benefit with the lowest risk. Should NIV be used in children as
well as adults? Here we present evidence supporting its use in
pediatric patients of different ages with ARF.
2. Case Reports2.1. Case 1A 14-year-old girl was admitted to this hospital in the
summer because of a recurring fever. She had had an episode
of meningitis at the age of 4e5 years and became chronically
dependent on valproic acid (Depakine) and carbamazepine
(Tegretol) at the age of 5e6 years to control seizures. Five
days prior to being admitted to the hospital, she developed aby Elsevier Taiwan LLC. All rights reserved.
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admission to the hospital, she woke up with dyspnea and was
feeling weak. She was brought to our pediatric outpatient
department. Her physical examination revealed that she had
breathing difficulties while using accessory respiratory mus-
cles. Her respiratory rate was 24e30 cycles/minute; blood
pressure was 113/71 mmHg; pulse rate was 82 beats/minute;
bilateral basal crackles extended from the lower third to half of
the lung fields; and, her oxygen saturation level was 90e91%.
Oxygen was administered through a non-rebreather mask and
the oxygen saturation level increased to 100%.
Her chest X-ray revealed a small patch and linear infiltra-
tion in the left and right upper lung fields, with a mild increase
in the lung markings in both lung fields. The chest computed
tomography revealed alveolar patchy opacities in the right and
left upper, and left lower lung fields, along with pleural effu-
sion. Penicillin G was administered intravenously. Approxi-
mately 3 hours after arrival, the patient was transferred to the
ward.
On the 5th day of hospitalization, the patient became
breathless and had an increased respiratory rate of 63 cycles/
minute, as well as a drop in her oxygen saturation level to 86%
while she was breathing 40% oxygen through a face mask,
with forceful contraction of accessory muscles. Her body
temperature was 40.3C and her blood pressure was 86/
67 mmHg. Auscultation disclosed rhonchi and diminished
breathing sounds in the left lung field.
Her arterial blood gas (ABG) results were pH: 7.425;
PaCO2: 36.8 mmHg; PaO2: 36.6 mmHg; HCO3: 23.6 mM/L;
Base Excess (BE): e0.7mM/L; and, SaO2: 71.4. The patient
was transferred to the intensive care unit (ICU).
In the ICU, oxygen saturation was 98% using NIV support
with a mask interface in spontaneous/time mode at a settingTable 1
Laboratory data.
Variable Reference range Case 1
adult Day 7
WBC (4.0e11.0) 4.51 8
RBC 3.87 3
Hb (11.3e15.3) 11.3 1
Hct (33e47) 0.334 0
AST (GOT) (10e32) 87 2
ALT (GPT) (3e31) 32
Na (135e145) 136 1
K (3.3e4.5) 3.2 4
CRP (<0.071e0.5) 42.86 1
Blood culture N
Aerobic culture MNF M
FiO2 z40% 1
Interface FM N
Blood Gas
pH 7.425 7
PaCO2 36.8 5
PaO2 36.6 6
HCO3 23.6 2
BE 0.7 0
SaO2 71.4 9
NG ¼ no growth; MNF ¼ mix normal flora; FM ¼ face mask; NRM ¼ nonrebrerate of 20 cycles/minute; inspiratory positive airway pressure
was 20 cm H2O; expiratory positive airway pressure was 9 cm
H2O; and, the O2 flow rate was 15 L/minute. We continuously
observed her and were prepared for intubation once we saw
signs of deterioration. Amoxicillin clavulanate was replaced
by cefotaxime and azithromycin. The aerobic culture of the
first sputum specimen showed mixed normal flora, whereas the
second specimen showed no growth. There was no order for a
blood culture. Two hours later, the ABG results were pH: 7.48;
PaCO2: 34 mmHg; PaO2: 138 mmHg; HCO3: 25.3mM/L; BE:
1.8 mM/L; and, SaO2: 99%.
On the 8th day, the patient’s body temperature was 37.8C,
blood pressure was 105/75 mmHg, and respiratory rate was 42
cycles/minute. She had a retraction respiratory pattern without
contractions of the accessory respiratory muscles. ABG results
were pH: 7.52; PaCO2: 33 mmHg; PaO2: 111 mmHg; HCO3:
26.9mM/L; BE: 4.0mM/L; and SaO2: 96%. The pulse rate
was 112 beats/minute. The chest film revealed resolution of the
pneumonic patch. Other laboratory data are shown in Table 1.2.2. Case 2A 6-year-old girl with Down syndrome was admitted to this
hospital in mid-spring because of increasing dyspnea, cough,
rhinorrhea, and fever. The patient had been in her usual state
of health until she began developing these symptoms 3e4 days
earlier, due to progressive shortness of breath. Her cough and
rhinorrhea were aggravated on the morning of admission. The
patient was brought to the emergency room at 4:23 AM. When
she arrived, she was acutely ill with a BP of 110/70 mmHg,
pulse rate of 128 beats/minute, and respiratory rate of 32 cy-
cles/minute. She had warm and pale skin, interrupted speech
caused by dyspnea, contractions in her accessory muscles, andCase 2 Case 1 Case 2 SI unit
Day 1 Day 9 Day 2
.61 9.38 8.28 103/mL
.99 3.61 3.96 106/mL
2.1 11 g/dL
.359 0.317 0.354
6 ~ ~ U/L
~ ~ U/L
40 134 ~ meq/L
3 ~ meq/L
4.71 25.99 3.3 mg/dL
G
NF NG
00% z60% z60%
RM 15L NIV 15L NIV 15L
.304 7.52 7.38
7.2 33 46.5 mmHg
2.4 111 132.4 mmHg
6.9 26.9 27.8 mM/L
.2 4 1.3 mM/L
2.2 98.5 98.6 %
athing mask; NIV ¼ noninvasive ventilation.
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on room air. An O2 flow rate of 12 L/minute was administered
through a non-rebreather mask. ABG results were pH: 7.304;
PaCO2: 57.2 mmHg; PaO2: 62.4 mmHg; HCO2: 26.9mM/L;
BE: 0.2mM/L; and, SaO2: 92.2%. She was subsequently
transferred to the ICU for further care.
In the ICU, NIV was used for oxygen and ventilation
support. The ABG results were pH: 7.38; PaCO2: 46.5 mmHg;
PaO2: 132.4 mmHg; HCO2: 27.8mM/L; BE: 0.2mM/L; and
SaO2: 98.6%. A chest radiograph revealed a patchy opacity in
the right lung field with pleural effusion. Blood culture showed
no growth. The aerobic culture of the first sputum specimen
showed mixed normal flora, whereas the second specimen
showed no growth. The patient was treated with cefotaxime
and azithromycin. The respiratory rate decreased to
20e25 cycles/minute. There was improved oxygenation and
CO2 retention. The chest X-ray revealed decreasing pleural
effusion. The laboratory data are shown in Table 1.
3. Discussion
The frequency of ARF is higher in infants and young
children than in adults. In addition, respiratory failure often
precedes cardiopulmonary arrest in children.1 Our cases
indicate the effectiveness of NIV in children with ARF.
In general, respiratory failure is classified as either hyp-
oxemic respiratory (type I)15 or hypercapnic (type II).16 Type I
respiratory failure is characterized by PaO2 < 60 mmHg with a
normal or low PaO2. The primary treatment is to administer
supplemental oxygen at a sufficient level to increase the
arterial oxygen saturation (SaO2) to >94%.When it is neces-
sary for a fraction of inspired oxygen (FiO2) to be >0.5 to
achieve the goal, the situation is often referred to as acute
hypoxemic respiratory failure. Type II respiratory failure is a
consequence of ventilation failure and occurs in conditions
where the respiratory pump has been affected, causing
depressed neural ventilatory drive, acute or chronic upper
airway obstruction, and alveolar hypoventilation characterized
by a PaCO2 > 50 mmHg. The onset of type II failure may be
insidious and may develop when respiratory muscle fatigue
complicates pre-existing disorders, such as pneumonia or
acute severe asthma (this is the current term for status asth-
maticus), which initially appears with hypoxemia with no
hypoventilation. Administration of oxygen alone is not an
appropriate treatment for hypercapnic respiratory failure and
could result in the retention of more carbon dioxide in pa-
tients. In addition to supplemental oxygen, therapies to reduce
the load on respiratory muscles and increase the level of
alveolar ventilation should be administered to children with
type II respiratory failure.
Case 1 was a type I failure from pneumonia. The major
cause was uneven or mismatched ventilation and perfusion
(intrapulmonary shunt) in the regional lung units. Case 2 was a
type II failure due to massive pleural effusion, along with
restrictive lung and respiratory muscle fatigue.
We followed the Bernd Sch€onhofer et al6 guidelines which
contain verified indications, contraindications, and criteria formonitoring and terminating NIV, as well as the advantages and
disadvantages of NIV vis-a-vis invasive ventilation. The main
goal of these guidelines is to encourage broader use of this
form of treatment in acute care based on scientific evidence.
Cambonie et al12 studied 12 patients with ARF, showing that
NIV avoided ETI in 60e100% of cases.
Abadesso et al17 studied 115 patients with ARF; the mean
hospital admission was 9.7 ± 9.5 days (median 8). The dif-
ference between the NIV success group and NIV failure group
was statistically significant.
In our cases, NIV reduced the need for intubation in ARF e
the same outcome achieved by studies in many countries. NIV
not only improved gas exchange by distending collapsed lung
units, but also reduced the load on the respiratory muscles.
The use of NIV in pediatric patients with ARF, based on our
cases, has the same effect as in adults.
We are not aware of any age limitations on the use of NIV,
but look forward to conducting a randomized clinical trial and
meta-analysis.
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